HPV Testing and Cervical Cancer Screening: Questions Women Should Ask Their Doctor
Questions to help you begin the conversation about HPV and HPV testing with your doctor. These can help determine if HPV testing is right for you.
Below are some questions to help you begin the conversation about HPV and HPV testing with your doctor. These can help determine if HPV testing is right for you.
- -Do you provide HPV testing as part of management of abnormal Pap test results?
- -Are you familiar with the new American Cancer Society guidelines that offer a preliminary recommendation, pending FDA approval, that HPV DNA testing may be used in conjunction with the Pap test, to safely screen women age 30 and over for cervical cancer as frequently as every three years?
- -How do you screen your patients for cervical cancer?
- -When should I be screened next for cervical cancer?
- -Are you aware of the new Consensus Guidelines published in the Journal of the American Medical Association (in April 2002) that recommend HPV testing as the preferred approach for managing women with inconclusive Pap results, particularly when a liquid-based Pap test is initially used for screening?
- -If I have an inconclusive Pap test result, can you ask the laboratory to perform an automatic ("reflex") HPV test from the same Pap sample before calling me with the results?
- -Can I talk with you about additional questions I may have regarding HPV and cervical cancer?
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More
Offering cervical and colorectal cancer screening at breast cancer screening found effective
August 26th 2024In a recent study, women overdue for cervical cancer and colorectal cancer screening were more likely to receive coverage when offered during their breast cancer screening visit.
Read More
